C4 Therapeutics, Inc. (CCCC) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $102.49M | -23.3% |
| 2024 | $133.62M | +2.5% |
| 2023 | $130.34M | -8.0% |
| 2022 | $141.61M | +20.9% |
| 2021 | $117.16M | -1.8% |
| 2020 | $119.35M | +0.1% |
| 2019 | $119.23M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $102.49M | -23.3% |
| 2024 | $133.62M | +2.5% |
| 2023 | $130.34M | -8.0% |
| 2022 | $141.61M | +20.9% |
| 2021 | $117.16M | -1.8% |
| 2020 | $119.35M | +0.1% |
| 2019 | $119.23M | — |